Nayoung Suh

2.9k citations
49 papers · 2.4k indexed · h-index 23
Topics
Mesenchymal stem cell research (12 papers)MicroRNA in disease regulation (8 papers)Sexual function and dysfunction studies (6 papers)

In The Last Decade

Nayoung Suh

48 papers receiving 2.4k citations

Peers

Nayoung Suh
Comparison fields: 5 of 121
  • Molecular Biology 1.4k
  • Cancer Research 540
  • Public Health, Environmental and Occupational Health 308
  • Aging 262
  • Physiology 243
Replace Makoto Fukuda with:
Makoto Fukuda Japan
Francesca Luchetti Italy
Elizabeth A. Pollina United States
Isabel Varela‐Nieto Spain
Miao Sun China
Jennifer L. Best United States
Gianluca Canettieri Italy
J. Eric Davies United Kingdom
Linda Koch United States
Nayoung Suh relative to Makoto Fukuda Japan Makoto Fukuda's profile →
Citations per field
00.5×1.5×2.3×
Makoto Fukuda · 1×
Citations per year

Countries citing papers authored by Nayoung Suh

Since Specialization
Citations

This map shows the geographic impact of Nayoung Suh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nayoung Suh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nayoung Suh more than expected).

Fields of papers citing papers by Nayoung Suh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nayoung Suh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nayoung Suh. The network helps show where Nayoung Suh may publish in the future.

Co-authorship network of co-authors of Nayoung Suh

This figure shows the co-authorship network connecting the top 25 collaborators of Nayoung Suh. A scholar is included among the top collaborators of Nayoung Suh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nayoung Suh. Nayoung Suh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 2
5 33
6 14
7 15
8 13
9 86
10 18
11 324
12 4
13 11
14 31
15 16
16 29
17 46
18 198
19 338
20 47

About Nayoung Suh

Nayoung Suh is a scholar working on Aging, Genetics and Urology, having authored 49 papers that have together received 2.4k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (12 papers), MicroRNA in disease regulation (8 papers) and Sexual function and dysfunction studies (6 papers). The work is most often cited by research in Aging (262 citations), Cancer Research (540 citations) and Molecular Biology (1.4k citations). Nayoung Suh has collaborated with scholars based in South Korea, United States and Czechia. Frequent co-authors include Robert Blelloch, Judith Kimble, Collin Melton, Inki Kim, Shin Bi Oh, Sujeong Kim, Joo‐Yong Lee, Sarah L. Crittenden, Christian R. Eckmann and Choung‐Soo Kim. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026